Cargando…

Corrigendum: The alteration of left ventricular strain in later-onset spinal muscular atrophy children

Detalles Bibliográficos
Autores principales:	Cui, Yiqin, Feng, Yijie, Xia, Yu, Fu, Xingpeng, Gong, Ming, Qian, Jingjing, Yu, Jin, Ye, Jingjing, Gao, Feng, Cheng, Hongqiang, Mao, Shanshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562856/ https://www.ncbi.nlm.nih.gov/pubmed/36246523 http://dx.doi.org/10.3389/fncel.2022.1028583

Ejemplares similares

The alteration of left ventricular strain in later-onset spinal muscular atrophy children
por: Cui, Yiqin, et al.
Publicado: (2022)

The Alterations of Gut Microbiome and Lipid Metabolism in Patients with Spinal Muscular Atrophy
por: Feng, Yijie, et al.
Publicado: (2023)

Editorial: Advances in spinal muscular atrophy
por: Sun, Jianli
Publicado: (2023)

Corrigendum: Case Report: Whole-Exome Sequencing With MLPA Revealed Variants in Two Genes in a Patient With Combined Manifestations of Spinal Muscular Atrophy and Duchenne Muscular Dystrophy
por: Xia, Yu, et al.
Publicado: (2021)

History of development of the life-saving drug “Nusinersen” in spinal muscular atrophy
por: Qiu, Jiaying, et al.
Publicado: (2022)

SMN post-translational modifications in spinal muscular atrophy
por: Riboldi, Giulietta M., et al.
Publicado: (2023)

Commentary: Current Status of Gene Therapy for Spinal Muscular Atrophy
por: Rossoll, Wilfried, et al.
Publicado: (2022)

Case Report: Whole-Exome Sequencing With MLPA Revealed Variants in Two Genes in a Patient With Combined Manifestations of Spinal Muscular Atrophy and Duchenne Muscular Dystrophy
por: Xia, Yu, et al.
Publicado: (2021)

Association between serum zinc level and lipid profiles in children with spinal muscular atrophy
por: Long, Qi, et al.
Publicado: (2022)

Nusinersen improves walking distance and reduces fatigue in later‐onset spinal muscular atrophy
por: Montes, Jacqueline, et al.
Publicado: (2019)

R-loop Mediated DNA Damage and Impaired DNA Repair in Spinal Muscular Atrophy
por: Cuartas, Juliana, et al.
Publicado: (2022)

NADPH oxidase 4 inhibition is a complementary therapeutic strategy for spinal muscular atrophy
por: El Khoury, Mirella, et al.
Publicado: (2023)

Anxiety and depression in school-age patients with spinal muscular atrophy: a cross-sectional study
por: Yao, Mei, et al.
Publicado: (2021)

Spinal Muscular Atrophy Type IIIb Complicated by Moyamoya Syndrome: A Case Report and Literature Review
por: Li, Jing, et al.
Publicado: (2022)

Survival motor neuron protein and neurite degeneration are regulated by Gemin3 in spinal muscular atrophy motoneurons
por: Miralles, Maria P., et al.
Publicado: (2022)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

A comparative analysis of body composition assessment by BIA and DXA in children with type II and III spinal muscular atrophy
por: Wang, Wenqiao, et al.
Publicado: (2022)

Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1/2 studies
por: Darras, Basil T., et al.
Publicado: (2019)

Nusinersen Treatment of Children with Later-Onset Spinal Muscular Atrophy and Scoliosis Is Associated with Improvements or Stabilization of Motor Function †
por: Dunaway Young, Sally, et al.
Publicado: (2023)

A homozygous missense variant in the YG box domain in an individual with severe spinal muscular atrophy: a case report and variant characterization
por: Li, Leping, et al.
Publicado: (2023)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US
por: Thokala, Praveen, et al.
Publicado: (2020)

Adult-Onset Spinal Muscular Atrophy due to Mutations in the VRK1 Gene
por: Sung, Angela, et al.
Publicado: (2021)

Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy
por: Schmitt, Linda-Isabell, et al.
Publicado: (2023)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Metabolic Dysfunction in Spinal Muscular Atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

Update on Biomarkers in Spinal Muscular Atrophy
por: Pino, Megan G, et al.
Publicado: (2021)

Onasemnogene abeparvovec for spinal muscular atrophy
Publicado: (2022)

Mitochondrial Dysfunction in Spinal Muscular Atrophy
por: Zilio, Eleonora, et al.
Publicado: (2022)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
por: Turner, Bradley J, et al.
Publicado: (2008)

Emerging concepts underlying selective neuromuscular dysfunction in infantile-onset spinal muscular atrophy
por: Gollapalli, Kishore, et al.
Publicado: (2021)

Amyotrophic Lateral Sclerosis and Progressive Muscular Atrophy
por: Williamson, R. T.
Publicado: (1907)

CORRIGENDUM to Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e8ivb4nadcg4jm9nnvv6f8dp14